you put the D.A. headline up so you deal with it grab your POM POM's and get to cheering the stagnate share price last time this stock ran insiders sold hand over fist.
Have you seen the contract what revenue is ONVO entitled or is it just a time material one where nothing is errrrr well what were revenues last qt.
BTW Einstein I.m not short but don't have my head in the sand or wherever it is you keep your head.
are you over here with that bogus site/printer go peddle it to wile e coyote or acme co.
after you get out of your mosque your going to short more you couldn't even get this to close at the LOD and i was selling some too......i'll buy when you push it sub 1
if the did not issue shares for compensation for a no sale quarter if well would look better imo
I thought the CC started at 8am eastern time should already be over if no analyst as all claim.......I'll dump some
LOL okay that was funny....i expect a flushing sound but maybe guidance ant the tax credit will help hold the line but still JV sold nothing speaks volumes IMO
As of October 10, 2013, each of the following named executive officers of Organovo Holdings, Inc. (“Organovo” or the “Company”) had adopted a stock trading plan in accordance with the guidelines established by the Securities and Exchange Commission under Rule 10b5-1 (“Rule 10b5-1”) of the Securities Exchange Act of 1934 (the “Exchange Act”): Keith Murphy, Chief Executive Officer and President, Sharon Presnell, Chief Technology Officer and Executive Vice President of Research & Development, and Eric David, Chief Strategy Officer. The Rule 10b5-1 trading plans allow these individuals to gradually diversify their holdings while minimizing any market effects of the trades and eliminating any market concern that the trades were made while these individuals were in possession of material, nonpublic information. Consistent with Rule 10b5-1, the Company’s Insider Trading Policy permits officers, directors and employees to implement Rule 10b5-1 trading plans provided that, among other things, an individual does not possess any material, nonpublic information at the time the individual adopts a plan. Each of these individuals have and will continue to file Form 4s reporting sales under their respective Rule 10b5-1 trading plans as required under Section 16 of the Exchange Act.
The broker serving as the designated agent for one of these Rule 10b5-1 trading plans will undertake to sell a specified number of shares each month if the stock trades above certain pre-set minimum prices established in the plan at the time it was adopted. The individual, after adopting the Rule 10b5-1, will have no control over the timing of any sales under the plan, and there is no assurance that any or all of the shares included in the plan will be sold.
Mr. Murphy adopted a Rule 10b5-1 trading plan to diversify his holdings and to make contributions to non-profit, charitable and public benefit corporations. Dr. Presnell adopted a Rule 10b5-1 trading plan to diversify her holdings and to
Organovo Holdings, Inc. has entered into an agreement with The Michael J. Fox Foundation for Parkinson’s Research to develop tissues for drug discovery. The parties have elected not to disclose terms...... from 2013 blast from the past secret secret ....still digging through the filings
well cannot fill 6.82 order 1k at the ask i put in to buy at the ask they filled 100 and moved price up.....short machines at work imo
the plan has been in place just after the big run up. I was just wonder when the next traunch hit the tape TIA